Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

Transcriptional activation by estrogen receptor (ER) is a key step to breast oncogenesis. Given previous findings that ADA3 is a critical component of HAT complexes that regulate ER function and evidence that overexpression of other ER coactivators such as SRC-3 is associated with clinical outcomes...

Full description

Bibliographic Details
Main Authors: Mirza, Sameer, Rakha, Emad A., Alshareeda, Alaa, Mohibi, Shakur, Zhao, Xiangshan, Katafiasz, Bryan J., Wang, Jun, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Ellis, Ian O., Green, Andrew R., Band, Hamid, Band, Vimla
Format: Online
Language:English
Published: Springer US 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552361/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552361/

Similar Items